LncRNA HULC augments high glucose-associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy.
Ankita SharmaShibasish ChowdhurySudeshna MukherjeeRajdeep ChowdhuryPublished in: Biology of the cell (2024)
Inhibition of HULC and YAP may represent a novel therapeutic strategy for PDAC. Furthermore, this study portrays the intricate molecular interplay between HULC, YAP and autophagy in PDAC pathogenesis.